Health Care [ 12/12 ] | Health Care Providers & Services [ 46/74 ]
NYSE | Common Stock
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally.
The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers.
It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care.
In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category.
Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners.
Hims & Hers Health, Inc. is based in San Francisco, California.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Aug 5, 24 | 0.06 Increased by +300.00% | 0.04 Increased by +50.00% |
| May 6, 24 | 0.05 Increased by +200.00% | 0.01 Increased by +400.00% |
| Feb 26, 24 | 0.01 Increased by +120.00% | -0.02 Increased by +150.00% |
| Nov 6, 23 | -0.04 Increased by +55.56% | -0.03 Decreased by -33.33% |
| Aug 7, 23 | -0.03 Increased by +70.00% | -0.05 Increased by +40.00% |
| May 8, 23 | -0.05 Increased by +37.50% | -0.07 Increased by +28.57% |
| Feb 27, 23 | -0.05 Increased by +66.67% | -0.07 Increased by +28.57% |
| Nov 7, 22 | -0.09 Decreased by -12.50% | -0.10 Increased by +10.00% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 24 | 401.56 M Increased by +77.13% | 75.59 M Increased by +1.10 K% | Increased by +18.82% Increased by +663.94% |
| Jun 30, 24 | 315.65 M Increased by +51.82% | 13.30 M Increased by +285.79% | Increased by +4.21% Increased by +222.38% |
| Mar 31, 24 | 278.17 M Increased by +45.81% | 11.13 M Increased by +210.54% | Increased by +4.00% Increased by +175.81% |
| Dec 31, 23 | 246.62 M Increased by +47.50% | 1.25 M Increased by +111.41% | Increased by +0.50% Increased by +107.74% |
| Sep 30, 23 | 226.70 M Increased by +56.52% | -7.57 M Increased by +59.84% | Decreased by -3.34% Increased by +74.34% |
| Jun 30, 23 | 207.91 M Increased by +83.08% | -7.16 M Increased by +63.63% | Decreased by -3.44% Increased by +80.14% |
| Mar 31, 23 | 190.77 M Increased by +88.30% | -10.07 M Increased by +38.06% | Decreased by -5.28% Increased by +67.10% |
| Dec 31, 22 | 167.20 M Increased by +97.41% | -10.91 M Increased by +65.00% | Decreased by -6.52% Increased by +82.27% |